1. Home
  2. RVSN vs ATHA Comparison

RVSN vs ATHA Comparison

Compare RVSN & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rail Vision Ltd.

RVSN

Rail Vision Ltd.

HOLD

Current Price

$0.38

Market Cap

20.9M

Sector

N/A

ML Signal

HOLD

Logo Athira Pharma Inc.

ATHA

Athira Pharma Inc.

HOLD

Current Price

$7.22

Market Cap

18.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVSN
ATHA
Founded
2016
2011
Country
Israel
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
18.2M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
RVSN
ATHA
Price
$0.38
$7.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
734.0K
3.1M
Earning Date
02-03-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$776,000.00
N/A
Revenue This Year
$28.46
N/A
Revenue Next Year
$755.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$2.20
52 Week High
$2.72
$8.36

Technical Indicators

Market Signals
Indicator
RVSN
ATHA
Relative Strength Index (RSI) 51.79 79.95
Support Level $0.33 $6.37
Resistance Level $0.37 $8.36
Average True Range (ATR) 0.03 0.48
MACD 0.00 0.39
Stochastic Oscillator 55.94 74.78

Price Performance

Historical Comparison
RVSN
ATHA

About RVSN Rail Vision Ltd.

Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

Share on Social Networks: